Lupin launches Ganirelix Acetate Injection, 250 mcg/0.5 ml, Health News, ET HealthWorld

[ad_1]

Mumbai: Lupin Limited announced the launch of Ganirelix Acetate Injection, 250 mcg/0.5 ml, single-dose prefilled syringe, after receiving approval from the United States Food and Drug Administration (US FDA).

Ganirelix Acetate Injection, 250 mcg/0.5 ml, single-dose prefilled syringe is a generic equivalent to the reference listed drug (RLD), Ganirelix Acetate Injection, 250 mcg/0.5 ml, of Organon USA LLC. It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation.

Ganirelix Acetate Injection had estimated annual sales of $87 million in the US (IQVIA MAT December 2023).

  • Published On Feb 15, 2024 at 02:06 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App


[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *